Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Isabelle Simoneau"'
Autor:
Alexia Rouland, Thomas Gautier, Damien Denimal, Laurence Duvillard, Isabelle Simoneau, David Rageot, Bruno Vergès, Benjamin Bouillet
Publikováno v:
Metabolites, Vol 14, Iss 9, p 487 (2024)
ApolipoproteinC1 (apoC1) is the main physiological inhibitor of the cholesterol ester transfer protein (CETP). Increased CETP activity is associated with macrovascular complications in patients with type 1 diabetes (T1D). ApoC1 has lost its ability t
Externí odkaz:
https://doaj.org/article/fb6d1a7fe0674277b327507c272724ef
Autor:
Damien Denimal, Victoria Bergas, Jean-Paul Pais-de-Barros, Isabelle Simoneau, Laurent Demizieux, Patricia Passilly-Degrace, Benjamin Bouillet, Jean-Michel Petit, Alexia Rouland, Amandine Bataille, Laurence Duvillard, Bruno Vergès
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-12 (2023)
Abstract Background Emerging evidence supports that dihydroceramides (DhCer) and ceramides (Cer) contribute to the pathophysiology of insulin resistance and liver steatosis, and that their circulating concentrations are independently associated with
Externí odkaz:
https://doaj.org/article/c20c51d1ec374a4897f888e61afcf59a
Autor:
Damien Denimal, Serge Monier, Isabelle Simoneau, Laurence Duvillard, Bruno Vergès, Benjamin Bouillet
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-9 (2022)
Abstract Background Reduced cholesterol efflux capacity (CEC) of HDLs is likely to increase cardiovascular risk in type 1 diabetes (T1D). We aimed to assess whether improvement of glycemic control in T1D patients is associated with changes in CEC in
Externí odkaz:
https://doaj.org/article/9ce08ac5d39141728cb71242dd3f4f4a
Publikováno v:
Pharmacy, Vol 11, Iss 4, p 129 (2023)
Vaccines are widely recognized as the most economically efficient strategy to combat infectious diseases. Community pharmacists, being highly accessible healthcare professionals, have the potential to significantly contribute to the promotion and fac
Externí odkaz:
https://doaj.org/article/674e8723ec004d84af3644957fe2b6c4
Autor:
Bruno Vergès, Alexia Rouland, Sabine Baillot‐Rudoni, Marie‐Claude Brindisi, Laurence Duvillard, Isabelle Simoneau, Pauline Legris, Jean‐Michel Petit, Benjamin Bouillet
Publikováno v:
Journal of Diabetes Investigation, Vol 12, Iss 4, Pp 619-624 (2021)
Abstract Obesity is increasing in patients with type 2 diabetes. A possible reduced association between fructosamine and glycated hemoglobin (HbA1c) in obese individuals has been previously discussed, but this has never been specifically evaluated in
Externí odkaz:
https://doaj.org/article/3d7b0294333642b6a0fc9b30ac9c0ffa
Autor:
Pauline Legris, Benjamin Bouillet, Justine Pâris, Pauline Pistre, Madeline Devaux, Stephanie Bost, Isabelle Simoneau, Sylvain Manfredi, Antoine Drouillard, Jean-Noel Bastie, Marie Chaix, Pamela Massoud, Alexia Rouland, Serge Aho, Mathieu Boulin, Jean-Michel Petit
Publikováno v:
Acta Diabetologica. 60:545-552
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31ffba6d5fdae9a559b9939dcbf16010
https://doi.org/10.1007/s00592-023-02032-z
https://doi.org/10.1007/s00592-023-02032-z
Autor:
Damien Denimal, Sara Benanaya, Serge Monier, Isabelle Simoneau, Jean-Paul Pais de Barros, Wilfried Le Goff, Benjamin Bouillet, Bruno Vergès, Laurence Duvillard
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 107:e3816-e3823
Objective To assess whether, in type 2 diabetes (T2D) patients, lipidomic abnormalities in high-density lipoprotein (HDL) are associated with impaired cholesterol efflux capacity and anti-inflammatory effect, 2 pro-atherogenic abnormalities. Design a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39c7d3b890a9240e579ff10e454c7f0a
https://doi.org/10.1210/clinem/dgac339
https://doi.org/10.1210/clinem/dgac339
Autor:
Alexia Rouland, Jean-Michel Petit, Bruno Vergès, Isabelle Simoneau, Pauline Legris, Benjamin Bouillet
Publikováno v:
Médecine des Maladies Métaboliques. 15:619-622
Resume Une patiente de 56 ans, diabetique de type 2, presentait des episodes d’hypoglycemies, qui ont persiste apres arret du traitement antidiabetique. Une epreuve de jeune authentifie une hypoglycemie organique, a 0,34 g/L, insulinemie a 6 mUI/L,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e84e3fbbb67c6c899bcdffd1cf252e7
https://doi.org/10.1016/j.mmm.2021.04.011
https://doi.org/10.1016/j.mmm.2021.04.011
Autor:
Pauline Legris, Benjamin Bouillet, Alexia Rouland, Jean-Michel Petit, Isabelle Simoneau, Bruno Vergès
Publikováno v:
Clinical Pharmacology : Advances and Applications
Introduction Inappropriate insulin secretion could be due to several diseases. Nesidioblastosis is characterized by diffuse hyperplasia of pancreatic beta cells, causing organic hypoglycemia. No pancreatic lesions are found on the imaging of patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffbde4dc5735fed8468f04553bdc4502
http://europepmc.org/articles/PMC7872904
http://europepmc.org/articles/PMC7872904
Autor:
Isabelle Simoneau, Marie-Claude Brindisi, Alexia Rouland, Pauline Legris, Bruno Vergès, S. Baillot-Rudoni, Laurence Duvillard, Benjamin Bouillet, Jean-Michel Petit
Publikováno v:
Journal of Diabetes Investigation
Journal of Diabetes Investigation, 2021, 12 (4), pp.619-624. ⟨10.1111/jdi.13383⟩
Journal of Diabetes Investigation, Vol 12, Iss 4, Pp 619-624 (2021)
Journal of Diabetes Investigation, 2021, 12 (4), pp.619-624. ⟨10.1111/jdi.13383⟩
Journal of Diabetes Investigation, Vol 12, Iss 4, Pp 619-624 (2021)
Obesity is increasing in patients with type 2 diabetes. A possible reduced association between fructosamine and glycated hemoglobin (HbA1c) in obese individuals has been previously discussed, but this has never been specifically evaluated in type 2 d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47c1fe49763317c3bec5b486a66fb070
http://europepmc.org/articles/PMC8015815
http://europepmc.org/articles/PMC8015815